Overview
- On Thursday HHS published a commissioned report called “Wolves in White Coats” and formally sent providers named in its claims analysis to the Department of Justice and the HHS Office of Inspector General for possible violations of federal law.
- The report flagged roughly $50 million in claims tied to an unspecified endocrine code (E34.9) used for puberty blockers and nearly $11 million tied to a precocious-puberty code (E30.1) for older teens.
- HHS said its claims totals are directional signals not findings and noted key limits in the analysis, including estimated ages from birth years and that listing on the referral does not prove fraud.
- Federal investigators and the OIG are expected to review underlying medical records and billing details, with potential outcomes ranging from demands for repayment and administrative penalties to civil enforcement or criminal charges.
- The referrals arrive after a May $10 million Texas settlement and recent CMS limits on federal Medicaid and CHIP funding for most gender‑affirming procedures for minors, a backdrop that raises fiscal and legal stakes for providers and families.